Across ALS, brain hemorrhage, and spinal cord injury, researchers are exploring very different ways to protect neurons and support recovery. One review found that traditional Chinese botanical medicines and plant-derived compounds may act on multiple ALS-related pathways, including inflammation, oxidative stress, mitochondrial dysfunction, and protein clearance. In severe subarachnoid hemorrhage, adropin reduced vasospasm, neuronal death, and microvascular thrombosis in mice when given within an early treatment window.
A third study focused on spinal cord injury, where increasing METTL14 activity in microglia enhanced autophagy, reduced inflammation, and improved neurological recovery. Together, these findings highlight a shared theme: targeting several biological processes at once may help limit damage and create better conditions for repair. Although much of the evidence remains preclinical, these approaches point toward new strategies for protecting the nervous system and improving recovery after disease or injury.
1. Traditional Chinese botanical medicines and plant-derived bioactive compounds in amyotrophic lateral sclerosis: mechanistic evidence, translational challenges, and therapeutic opportunities
A large review found that traditional Chinese botanical medicines and plant-derived compounds may influence several ALS-related mechanisms, including inflammation, oxidative stress, mitochondrial dysfunction, and protein clearance. The evidence is still mostly preclinical, but it highlights promising multi-target strategies for future ALS treatment research.
2. Adropin Reduces Early Brain Injury and Delayed Cerebral Ischemia After Severe Subarachnoid Hemorrhage in a Mouse Model
In a mouse model of severe subarachnoid hemorrhage, adropin reduced vasospasm, neuronal death, and microvascular thrombosis while improving long-term behavior when given within six hours. The findings suggest adropin may help protect the brain after SAH, with treatment timing playing a critical role.
3. Microglial METTL14 mediated m⁶A regulation of ATG13 promotes autophagy and functional recovery after spinal cord injury
Researchers found that boosting METTL14 in microglia enhanced autophagy, reduced inflammation, and improved neurological recovery after spinal cord injury. The findings point to the METTL14-ATG13 pathway as a potential target for promoting spinal cord repair.
If you’d like to stay informed of the latest publications and breakthroughs in neuron regeneration, join our email newsletter to the right (or below on mobile). We send out weekly updates with the latest papers and studies, as well as podcast episodes with the people driving Neuroregenerative breakthroughs.
